GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Cash-to-Debt

American Vietnamese Biotech (HSTC:AMV) Cash-to-Debt : 0.00 (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. American Vietnamese Biotech's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, American Vietnamese Biotech couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for American Vietnamese Biotech's Cash-to-Debt or its related term are showing as below:

HSTC:AMV's Cash-to-Debt is not ranked *
in the Biotechnology industry.
Industry Median: 6.49
* Ranked among companies with meaningful Cash-to-Debt only.

American Vietnamese Biotech Cash-to-Debt Historical Data

The historical data trend for American Vietnamese Biotech's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

American Vietnamese Biotech Cash-to-Debt Chart

American Vietnamese Biotech Annual Data
Trend
Cash-to-Debt

American Vietnamese Biotech Quarterly Data
Cash-to-Debt

Competitive Comparison of American Vietnamese Biotech's Cash-to-Debt

For the Biotechnology subindustry, American Vietnamese Biotech's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Vietnamese Biotech's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Cash-to-Debt falls into.



American Vietnamese Biotech Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

American Vietnamese Biotech's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

American Vietnamese Biotech's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Vietnamese Biotech  (HSTC:AMV) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


American Vietnamese Biotech Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


American Vietnamese Biotech (HSTC:AMV) Business Description

Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus

Atlis Motor Vehicles Reaches 2 Gigawatt-Hours in Customer Demand for Batteries

By Stock market mentor Stock market mentor 01-11-2023